Androgenetic alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: One side of the patients head is treated with exosome injection (5 sessions at an interval of 3 weeks) and topical minoxidil 5% (15 weeks). Intervention 2: Control
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age 18 years and above and less than 45 years Hamilton score 2 to 5 in male and female hair loss Complete consent of the patient to participate in the plan
Exclusion criteria
Exclusion criteria: Patients with malignancy Receiving chemotherapy in the last 5 years Patients with sepsis smoking Pregnancy or breastfeeding Active wound or infection at the treatment site Receiving any topical or systemic medication in the last 3 months for hair loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density. Timepoint: before the start of treatment and three and six months after the start of the intervention. Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During treatment. Method of measurement: Questionnaire and observation.;Satisfaction. Timepoint: A month after the last session. Method of measurement: Satisfaction Questionnaire and visit.;Tolerability. Timepoint: During treatment. Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed